Trial Profile
A Phase II Study Evaluating the Efficacy of Gemcitabine, Carboplatin, and Dexamethasone and Rituximab for Previously Treated Lymphoid Malignancies.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Dexamethasone (Primary) ; Gemcitabine (Primary) ; Rituximab (Primary)
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma; Hodgkin's disease; Mantle-cell lymphoma; Marginal zone B-cell lymphoma; Non-Hodgkin's lymphoma; T-cell lymphoma; Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 25 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Apr 2008 The expected completion date for this trial is now 1 Aug 2010.
- 08 Apr 2008 Status changed from recruiting to completed according to clinicaltrials.gov record.